,i  #aadth ,,congress  #ast ,session    
,h4 ,r4 #cdda  ,,in ,,the ,,house ,,of  
,,representatives  ,august #d1 #bjae    
,ms4 ,herrera ,beutler 7for herself and 
,ms4 ,roybal-,allard7 introduced the    
following bill2 which was referred to   
the ,committee on ,energy and ,commerce 
,a ,,bill  ,to amend the ,public ,health
 ,service ,act to establish education   
programs for patients and health care   
providers regarding cell-free ,,dna     
prenatal screening1 and for other       
purposes4  #a4 ,short title ,this ,act  
may be cited as the ,accurate ,education
 for ,prenatal ,screenings ,act4  #b4   
,cell-,free ,,dna ,prenatal ,screening  
,education ,programs ,part ,b of title  
,,iii of the ,public ,health ,service   
,act is amended by inserting1 after     
section #cag,t 7#db ,u4,s4,c4           
#bdg;b-#bb71 the following3  #cag,u4    
,cell-,free ,,dna ,prenatal ,screening  
,education ,programs  7a7 ,education    
programs ,with respect to cell-free     
,,dna prenatal screening1 the           

,secretary1 acting through the ,director
 of the ,centers for ,disease ,control  
and ,prevention1 shall develop1         
implement1 and maintain two programs1   
one for patients and one for health care
 providers1 to educate patients and     
health care providers regarding matters 
including--  7#a7 the purposes and      
definitions of such screenings2  7#b7   
the reasons for patients and health care
 providers to consider such screenings2 
7#c7 the conditions such screenings may 
detect1 including accurate and          
up-to-date information about such       
conditions' clinical features1          
prognoses1 and treatments according to  
relevant national disability            
organizations and medical professional  
societies2  7#d7 the risks and benefits 
of1 and alternatives to1 the various    
methods of administering such screenings
 and prenatal diagnostic testings1      
including the option to forego such     
screenings and testings1 as per         
guidelines established by medical       

professional societies2  7#e7 the       
possible results of such screenings2    
7#f7 the accuracy of the results of such
 screenings1 including positive         
predictive value1 negative predictive   
value1 specificity1 sensitivity1 the    
inability of such screenings to reliably
 diagnose chromosomal abnormalities1 and
 the fact that such screenings may yield
 false-positive and false-negative      
results2  7#g7 the need for diagnostic  
testing1 and counseling by a genetics   
professional1 for patients whose        
screenings yield positive1 abnormal1 or 
indeterminate results2 and  7#h7 the    
need for communication of screening     
results to patients and appropriate     
follow up per guidelines established by 
medical professional societies4  7b7    
,materials ,each program developed under
 this section shall include the         
provision of materials that-- 7#a7      
contain information that is             
peer-reviewed1 balanced1 accurate1 and  
up-to-date2  7#b7 enable the respective 

target audience to understand the       
available options with regards to       
cell-free ,,dna prenatal screenings1    
other prenatal screenings1 and          
diagnostic tests2  7#c7 promote the     
informed consent1 and enhance the       
decision-making processes of1 the       
respective target audience before and   
after such screenings2  7#d7 contain    
information that appropriately addresses
 the diversity of the patient           
population1 including patients          
proficient in languages other than      
,english2 and  7#e7 contain contact     
information for relevant services and   
support organizations for patients4  7c7
 ,assessment ,in developing1            
implementing1 and maintaining programs  
and materials under this section1 the   
,secretary1 acting through the ,director
 of the ,centers for ,disease ,control  
and ,prevention1 shall--  7#a7 consult  
with relevant medical professional1     
disability support1 patient advocacy1   
parents1 and genetics professionals     

organizations2  7#b7 consult with       
companies and laboratories that perform 
cell-free ,,dna prenatal screenings or  
develop the technologies for such       
screenings2  7#c7 assess and evaluate   
existing education activities and       
materials for health care providers and 
patients related to such screenings2 and
  7#d7 take the results of such         
consultations1 assessment1 and          
evaluation into account in developing   
educational programs and materials under
 this section4  7d7 ,annual report ,not 
later than #af months after the date of 
enactment of this section and annually  
thereafter1 the ,secretary shall submit 
a progress report to the ,congress with 
respect to--  7#a7 the development and  
implementation of the education programs
 established under this section2  7#b7  
the accessibility of each program to its
 respective target audience2  7#c7 the  
adoption of each program by its         
respective target audience2 and  7#d7   
the ,secretary's efforts to ensure      

health care providers and patients      
receive the materials created pursuant  
to this section4  7e7 ,deadline ,the    
,secretary shall develop and implement  
the education programs required by      
section #cag,u of the ,public ,health   
,service ,act 7as added by subsection   
7a77 not later than #a year after the   
date of enactment of this ,act  4